Chandrasekar Gopalakrishnan

MedicineEconomics, Econometrics and Finance

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

1in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 1 indexed paper attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

Papers

Driven by 2 papers. Top paper: “Preferential prescribing and utilization trends of diabetes medications among patients with renal impairment: Emerging role of linagliptin and other dipeptidyl peptidase 4 inhibitors”.

Preferential prescribing and utilization trends of diabetes medications among patients with renal impairment: Emerging role of linagliptin and other dipeptidyl peptidase 4 inhibitors

Endocrinology, Diabetes & Metabolism(2018)10.1002/edm2.5

N/A

0.373DataRank · unranked

11 citations

Chandrasekar Gopalakrishnan, Dorothee B. Bartels, Kimberly G. Brodovicz, Jun Liu, Sebastian Schneeweiss +1 more

Comparison of a new 3-item self-reported measure of adherence to medication with pharmacy claims data in patients with cardiometabolic disease

American Heart Journal(2020)10.1016/j.ahj.2020.06.012

N/A

0DataRank · unranked

27 citations

Constance P. Fontanet, Thomas Isaac, Chandrasekar Gopalakrishnan, Thomas D. Sequist, Joshua J. Gagne +5 more